Next week, San Francsico will play host to thousands of healthcare executives and investors for the first major healthcare event of the year, JP Morgan Healthcare Conference. The event highlights value to the entire spectrum of the life sciences sector from investment to personal health. Here, Oliver Wyman's Sam Glick shares what to expect and where you might find him.
1. In light of the uncertainty regarding the future healthcare landscape, what do you think the mood will be like at this year’s conference?
I expect nervous optimism. At its core, JP Morgan is about matching investors with investment opportunities, and on balance the healthcare investment environment is a good one, with the stock market on an upswing, drug and technology innovation continuing at a rapid pace, and the Trump administration likely to have a light touch when it comes to M&A.
On the other hand, as a whole, healthcare was the only major industry to have negative total returns in 2016, and there are major headwinds in terms of government funding in particular. I expect there will still be plenty of deals done – even if people don’t quite know what the future holds.
2. Why is JP Morgan Healthcare one of the “must attend” events for industry leaders?
It’s the ultimate example of network effects. JPMorgan is a “must attend” event because everyone attends it! Plus, the parties are pretty good.
3. JP Morgan Conference Week Highlights
- StartUp Health Festival: The 2017 Festival convenes more than 2,000 entrepreneurs, healthcare leaders, scientists, doctorpreneurs, investors and transformation drivers from around the world. Speakers include Jonathan Bush, CEO, athenahealth; Esther Dyson, Executive Founder, Way to Wellville; and Greg Simon, Executive Director, White House Cancer Moonshot Task Force.
- Health 2.0 WinterTech: WinterTech prides its event on sharing insider insights on investing trends in healthcare technology. The event brings together major tech companies, VCs, entrepreneurs, policy makers, and more. Speakers include Owen Tripp, Co-Founder and CEO, Grand Rounds, Inc.; Glen Tullman, CEO, Livongo Health; and Noah Craft, Co-Founder and CEO, Science 37.